Walleye Trading’s Psyence Biomedical Warrant PBMWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-44,080
Closed -$635 4820
2024
Q4
$635 Buy
44,080
+19,726
+81% +$262 ﹤0.01% 4168
2024
Q3
$307 Hold
24,354
﹤0.01% 4028
2024
Q2
$256 Hold
24,354
﹤0.01% 4175
2024
Q1
$1.71K Buy
+24,354
New +$1.52K ﹤0.01% 4540

Other funds holding PBMWW

Walleye Trading's PBMWW Position: Q1 2025 in Review

Walleye Trading sold out of Psyence Biomedical Warrant (PBMWW) in Q1 2025, closing a stake of 44,080 shares — an estimated $635 sold.

Walleye Trading first reported a position in PBMWW in Q1 2024 and held it in 4 quarters. The position peaked at $1.71K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q1 2025.

  • Walleye Trading reported no remaining Psyence Biomedical Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 44,080 Psyence Biomedical Warrant shares in Q1 2025, an estimated $635.
  • Walleye Trading first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 4 quarters.
  • Walleye Trading's Psyence Biomedical Warrant position peaked at $1.71K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.